ERBB2 and breast cancer: Similarly, up-regulated terminal differentiation-induced non-coding RNA (TINCR) significantly promotes EMT-associated protein expression and HER-2 expression in trastuzumab-resistant BC cells via the miR-125b-HER-2/Snail-1 signaling pathway [157].